Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04362553 · ClinicalTrials.gov registry record
Advanced Wireless, Wearable Sensors for Continuous Hemodynamic Monitoring
A clinical trial of Congestive Heart Failure, sponsored by Northwestern University.
- Completed
- Registry status
- 42
- Enrollment target
- 1
- Study location
NCT04362553: Completed study of Congestive Heart Failure, sponsored by Northwestern University.
NCT04362553 is a study of Congestive Heart Failure that has completed, run by Northwestern University. The registered enrollment target is 42 participants, below the 329-participant average among 51 other Congestive Heart Failure trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04362553, a study of Congestive Heart Failure, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 42 participants
- Enrollment target
- 1
- Study location
Study Summary
Percent agreement of vital signs monitoring between the experimental sensor and standard of care monitoring
Primary Outcome
Percent agreement with pilot sensor and current standard of vital signs monitoring
Conditions Studied
Interventions
- DEVICE wearable vital signs sensor
Study Locations (1)
Illinois
- Northwestern Memorial Hospital - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2020-06-01 |
| Est. Completion | 2022-09-05 |
What the finished NCT04362553 record still lists
NCT04362553 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 42 participants, a relatively small participant target, below the 329-participant average among 51 other Congestive Heart Failure trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Congestive Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which wearable vital signs sensor is the first listed.
NCT04362553 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT04362553 about?
NCT04362553 is a clinical study titled "Advanced Wireless, Wearable Sensors for Continuous Hemodynamic Monitoring". Percent agreement of vital signs monitoring between the experimental sensor and standard of care monitoring
What is the current status of trial NCT04362553?
This trial is currently completed. The enrollment target is 42 participants. The study started on 2020-06-01. Estimated completion is 2022-09-05.
What conditions does trial NCT04362553 study?
This clinical trial studies the following conditions: Congestive Heart Failure.
What interventions are being tested in trial NCT04362553?
The interventions under investigation include: wearable vital signs sensor (DEVICE).
Who is sponsoring clinical trial NCT04362553?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04362553 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Congestive Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04362553's enrollment target sits among peer trials
42 39th of 51 higher than 13 of 51 other Congestive Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Congestive Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Palliative Care for People With HF
RECRUITING
-
Circulating Markers for Ischemic Heart Disease
RECRUITING
-
Stress and Congestive Heart Failure
RECRUITING · NA
-
Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
RECRUITING · NA
-
Care Transitions App for Patients With Multiple Chronic Conditions
RECRUITING · NA
-
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02852213 · 42 participants · Phase 1
A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients
- NCT03136146 · 42 participants · Phase 2
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
- NCT03178149 · 42 participants · Phase 1
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- NCT03663530 · 42 participants · NA
Circadian Misalignment and Energy Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI